ATYR
aTyr Pharma Inc.
$0.87
-$0.02(-2.48%)
30
Overall
45
Value
9
Tech
36
Quality
Market Cap
$97.21M
Volume
3.64M
52W Range
$0.68 - $7.29
Target Price
$5.30
Order:
Income Statement
| Metric | Trend | Chart | 2015 Dec | 2016 Dec | 2017 Dec | 2018 Dec | 2019 Dec | 2020 Dec | 2021 Dec | 2022 Dec | 2023 Dec | 2024 Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| REVENUE | ||||||||||||
| Total Revenue | -- | $-57.9M | -- | -- | $2.2M | $10.5M | -- | $10.4M | $353.0K | $235.0K | ||
| Total Revenue | -- | $-57.9M | -- | -- | $422.0K | $10.5M | -- | $10.4M | $353.0K | $235.0K | ||
| GROSS PROFIT | ||||||||||||
| Gross Profit | -- | $-57.9M | -- | -- | $422.0K | $10.5M | -- | $10.4M | $353.0K | $235.0K | ||
| OPERATING EXPENSES | ||||||||||||
| Operating Expenses | $-47.6M | $-57.9M | $47.1M | $32.8M | $23.4M | $26.4M | $34.0M | $56.8M | $55.3M | $68.1M | ||
| Research & Development | $34.5M | $42.8M | $30.1M | $20.4M | $14.0M | $17.3M | $23.3M | $42.8M | $42.3M | $54.4M | ||
| Research Expense | $34.5M | $42.8M | $30.1M | $20.4M | $14.0M | $17.3M | $23.3M | $42.8M | $42.3M | $54.4M | ||
| Selling, General & Administrative | $13.1M | $15.1M | $17.1M | $12.4M | $9.4M | $9.1M | $10.8M | $14.0M | $13.0M | $13.8M | ||
| General & Administrative Expenses | $13.1M | $15.1M | $17.1M | $12.4M | $9.4M | $9.1M | $10.8M | $14.0M | $13.0M | $13.8M | ||
| Salaries & Wages | $-4.9M | $-5.0M | $-6.8M | $-3.4M | -- | -- | -- | $2.2M | $2.6M | $3.0M | ||
| Depreciation & Amortization | -- | -- | $-713.0K | $-746.0K | $635.0K | $600.0K | $500.0K | $200.0K | $600.0K | $700.0K | ||
| Depreciation & Amortization | -- | -- | $-713.0K | $-746.0K | $635.0K | $600.0K | $500.0K | $200.0K | $600.0K | $700.0K | ||
| Other Operating Expenses | $-47.6M | $-57.9M | $-47.1M | $-32.8M | $-1.7M | $-402.0K | $-534.0K | $-3.0M | $-5.4M | $-6.7M | ||
| OPERATING INCOME | ||||||||||||
| Operating income | $-47.6M | $-115.8M | $-47.1M | $-32.8M | $-23.0M | $-15.9M | $-34.0M | $-46.4M | $-54.9M | $-67.9M | ||
| EBITDA | $-46.9M | $-56.5M | $-47.5M | $-30.2M | $-20.9M | $-14.6M | $-32.7M | $-44.1M | $-49.8M | $-64.8M | ||
| NON-OPERATING ITEMS | ||||||||||||
| Interest Income Operating | -- | -- | -- | -- | -- | $10.0K | -- | -- | -- | -- | ||
| Intinc | $-386.0K | $65.0K | -- | $-1.7M | $13.0K | -- | -- | -- | -- | -- | ||
| Net Non-Operating Interest Income/Expense | $-386.0K | $65.0K | -- | $-1.7M | $13.0K | $1.5M | -- | -- | -- | -- | ||
| Other Income/Expense | $-29.0K | $-36.0K | $1.1M | $-3.8M | $785.0K | $319.0K | $-238.0K | $1.1M | $-4.5M | $-3.9M | ||
| Other Special Charges | $29.0K | $36.0K | $-1.1M | $3.4M | $-785.0K | $-319.0K | $238.0K | $1.1M | $4.5M | $3.9M | ||
| PRE-TAX INCOME | ||||||||||||
| EBIT | $-48.9M | $-58.1M | $-48.2M | $-30.7M | $-22.0M | $-15.9M | $-34.0M | $-45.7M | $-52.6M | $-66.4M | ||
| Pre-Tax Income | $-48.0M | $-57.9M | $-48.2M | $-30.7M | $-22.0M | $-16.2M | $-33.8M | $-45.3M | $-50.4M | $-64.0M | ||
| INCOME TAX | ||||||||||||
| Tax Provision | $-3.6M | $-49.0K | $-1.3M | $-770.0K | $-49.0K | $-12.0K | $-2.3M | $-380.0K | $-2.2M | $-2.4M | ||
| NET INCOME | ||||||||||||
| Net Income | $-48.0M | $-115.7M | $-48.2M | $-30.7M | $-23.6M | $-16.2M | $-33.8M | $-45.3M | $-50.4M | $-64.0M | ||
| Net Income (Continuing Operations) | $-48.0M | $-115.7M | $-48.2M | $-30.7M | $-23.6M | $-16.2M | $-33.8M | $-45.3M | $-50.4M | $-64.0M | ||
| Net Income (Discontinued Operations) | $-48.0M | $-115.7M | $-48.2M | $-30.7M | $-23.6M | $-16.2M | $-33.8M | $-45.3M | $-50.4M | $-64.0M | ||
| Net Income (Common Stockholders) | $-48.0M | $-115.7M | $-48.2M | $-30.7M | $-21.8M | $-16.2M | $-33.8M | $-45.3M | $-50.4M | $-64.0M | ||
| TOTALS | ||||||||||||
| Total Expenses | $-47.6M | $-57.9M | $47.1M | $32.8M | $23.4M | $26.4M | $34.0M | $56.8M | $55.3M | $68.1M | ||
| SHARE & EPS DATA | ||||||||||||
| Average Shares Outstanding | $1.1M | $1.7M | $1.8M | $2.1M | $3.4M | $9.2M | $19.1M | $28.4M | $53.6M | $74.3M | ||
| Average Shares Outstanding (Diluted) | $1.1M | $1.7M | $1.8M | $2.1M | $3.4M | $9.2M | -- | $28.4M | $53.6M | $74.3M | ||
| Shares Outstanding | $1.7M | $1.7M | $2.1M | $2.5M | $9.4M | $16.0M | $27.8M | $53.2M | $67.8M | $88.9M | ||
| Basic EPS | -- | -- | -- | -- | $-7.03 | $-1.77 | $-1.77 | $-1.6 | $-0.94 | $-0.86 | ||
| Basic EPS (Continuing Operations) | -- | -- | -- | -- | $-7.03 | $-1.77 | $-1.77 | $-1.6 | $-0.94 | $-0.86 | ||
| Diluted EPS | $-42.42 | $-34.16 | $-26.18 | $-16.1 | $-7.03 | $-1.77 | $-1.77 | $-1.6 | $-0.94 | $-0.86 | ||
| Diluted EPS (Continuing Operations) | -- | -- | $-26.18 | $-16.1 | -- | -- | -- | $-1.6 | $-0.94 | $-0.86 | ||
| OTHER METRICS | ||||||||||||
| Accretion On Preferred Stock | $15.0K | -- | -- | -- | -- | -- | -- | -- | -- | -- | ||
| Acquired In Process Rn D Income | -- | -- | $-48.2M | $36.0K | -- | -- | -- | -- | -- | -- | ||
| Gain On Sale Of P P E | -- | -- | -- | $379.0K | -- | -- | -- | -- | -- | -- | ||
| Interest Expense Operating | $-925.0K | $-225.0K | -- | -- | -- | -- | -- | -- | -- | -- | ||
| Minority Interests | -- | -- | -- | -- | $160.0K | $6.0K | $9.0K | $5.0K | $8.0K | $-1.0K | ||
| Other Gand A | $13.1M | $15.1M | $17.1M | $12.4M | $9.4M | $9.1M | $10.8M | $14.0M | $13.0M | $13.8M | ||
| Otherunder Preferred Stock Dividend | $15.0K | -- | -- | -- | -- | -- | -- | -- | -- | -- | ||
| Preferred Stock Dividends | $15.0K | -- | -- | -- | -- | -- | -- | -- | -- | -- | ||
| Rent And Landing Fees | $13.1M | $15.1M | $-900.0K | $-1.0M | $1.0M | $1.0M | -- | -- | -- | -- | ||
Financial data is updated quarterly and may not reflect the most recent earnings.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | ATYR | $0.87 | -2.5% | 3.64M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |